康芝药业: 关于聘请公司2025年度审计机构的公告

Group 1 - The company has decided to reappoint Zhongshun Zhonghuan Accounting Firm as its auditor for the year 2025, pending approval from the shareholders' meeting [1][6][7] - Zhongshun Zhonghuan has been recognized for its diligent and objective auditing practices since its appointment, demonstrating the capability to provide auditing services for listed companies [1][2] - The audit fees for the 2025 annual audit are set at 720,000 yuan, while the internal control audit fees are set at 280,000 yuan, with no changes in the fees compared to the previous year [5][6] Group 2 - Zhongshun Zhonghuan was established in 1987 and is one of the first large accounting firms approved to conduct securities and futures-related business audits in China [2] - As of the end of 2024, Zhongshun Zhonghuan has 216 partners and 1,304 registered accountants, with 723 of them having signed audit reports for securities services [2][3] - The firm has audited 244 listed companies across various industries, including manufacturing, wholesale and retail, real estate, and more, with a total audited revenue of approximately 2.17 billion yuan in 2024 [2][3]